{"id":2068,"date":"2004-03-01T12:03:00","date_gmt":"2004-03-01T11:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/schoenlein-henoch-purpura-durch-angiotensin-rezeptor-blocker-at-ii-rb"},"modified":"2004-03-01T12:03:00","modified_gmt":"2004-03-01T11:03:00","slug":"schoenlein-henoch-purpura-durch-angiotensin-rezeptor-blocker-at-ii-rb","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/schoenlein-henoch-purpura-durch-angiotensin-rezeptor-blocker-at-ii-rb","title":{"rendered":"Sch\u00f6nlein-Henoch-Purpura durch Angiotensin-Rezeptor-Blocker (AT-II-RB)"},"content":{"rendered":"<p>AT-II-RB haben ein g\u00fcnstiges UAW-Profil. Seltene, bisher bekannte UAW sind Lebersch\u00e4den, Pankreatitis, Angio\u00f6dem, Verschlechterung der Nierenfunktion und Geschmacksst\u00f6rungen (s.a. 1, 2, 3). Im Brit. Med. J. berichten A. Morton et al. aus Brisbane\/Australien in der Rubrik \u201eDrug Points\u201d \u00fcber einen Fall von akut aufgetretener Purpura mit \u00d6demen an beiden Beinen bei einem 73-j\u00e4hrigen Mann, der [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AT-II-RB haben ein g\u00fcnstiges UAW-Profil. Seltene, bisher bekannte UAW sind Lebersch\u00e4den, Pankreatitis, Angio\u00f6dem, Verschlechterung der Nierenfunktion und Geschmacksst\u00f6rungen (s.a. 1, 2, 3). Im Brit. Med. J. berichten A. Morton et al. aus Brisbane\/Australien in der Rubrik \u201eDrug Points\u201d \u00fcber einen Fall von akut aufgetretener Purpura mit \u00d6demen an beiden Beinen bei einem 73-j\u00e4hrigen Mann, der [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[316,309,312,314,313,315,317,320,311,307,319,310,1226,4247,306,4246],"class_list":["post-2068","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-candesartan","tag-purpura-schoenlein-henoch","tag-sartane","tag-schoenlein-henoch-purpura"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2068"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2068\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}